New blood panel aims to catch liver cancer before it spreads
Diagnosis
Ongoing
Researchers are testing a blood test panel called Glycotest HCC to see if it detects early-stage liver cancer better than the standard alpha-fetoprotein (AFP) test. The study includes 766 people with cirrhosis, some of whom have early liver cancer and some who do not. Participant…
Sponsor: Glycotest, Inc. • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC